Patents-Review.com
ClassID:

170440 ⎘

G01N2333/56 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving cytokines; Interferons [IFN] IFN-alpha

Recent Application in this class:
#1
20250231177
2025-07-17

METHOD OF CHARACTERIZING TUMORS

 #2
20250027133
2025-01-23

MULTIPLEX CELLULAR ASSAYS FOR SCREENING AND QUALITY ASSESSMENT OF ENGINEERED CELLS

 #3
20240426810
2024-12-26

ANTI-PD1 THERAPY BASED ON RESPONSE TO IFN-I STIMULATION

 #4
20240293478
2024-09-05

IMMUNOSTIMULATORY BACTERIA FOR CONVERTING MACROPHAGES INTO A PHENOTYPE AMENABLE TO TREATMENT, AND COMPANION DIAGNOSTIC FOR IDENTIFYING SUBJECTS FOR TREATMENT

 #5
20240183864
2024-06-06

Compositions and methods for detecting proteinopathies

 #6
20220048997
2022-02-17

Combination of a PD-1 antagonist, an ATR inhibitor and a platinating agent for the treatment of cancer

 #7
20210325407
2021-10-21

SARS-COV-2 infection biomarkers and uses thereof

 #8
20210221883
2021-07-22

Human anti-IFN-α antibodies

 #9
20210109109
2021-04-15

METHOD FOR MEASURING SYSTEMIC CHRONIC INFLAMMAGING

 #10
20200408777
2020-12-31

QUANTITATIVE BIOMARKERS OF EHV-1 SUSCEPTIBILITY AND PROTECTION

 #11
20200284805
2020-09-10

Biomarkers related to organ function

 #12
20200123198
2020-04-23

Peptide Libraries and Methods of Use

 #13
20190071499
2019-03-07

Human anti-IFN-α antibodies

 #14
20190033321
2019-01-31

Early Diagnosis of Autoimmune and Inflammatory Disorders

 #15
20180120334
2018-05-03

Compositions and methods for detecting proteinopathies

 #16
20180080943
2018-03-22

Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment

 #17
20170299590
2017-10-19

METHODS AND COMPOSITIONS FOR SYSTEMIC LUPUS ERYTHEMATOSUS

 #18
20170102392
2017-04-13

Early Diagnosis of Autoimmune and Inflammatory Disorders

 #19
20170051055
2017-02-23

Human anti-IFN-α antibodies

 #20
20160231330
2016-08-11

Biomarkers related to organ function

 #21
20160222466
2016-08-04

Activities of multiple cancer-related pathways are associated with BRAF mutation and predict the resistance to BRAF/MEK inhibitors in melanoma cells

 #22
20160186259
2016-06-30

Gene and protein expression properties of adherent stromal cells cultured in 3D

 #23
20150232930
2015-08-20

USE OF POST-TRANSCRIPTIONAL GENE SILENCING FOR IDENTIFYING NUCLEIC ACID SEQUENCES THAT MODULATE THE FUNCTION OF A CELL

 #24
20150174205
2015-06-25

Method of diagnosis and treatment

 #25
20150160236
2015-06-11

Methods For Determining Anti-TNF Therapeutic Response

 #26
20120244148
2012-09-27

Anti-interferon-α antibodies

 #27
20120219555
2012-08-30

Methods of treating lupus

 #28
20120035347
2012-02-09

INTERFERON-ALFA SENSITIVITY BIOMARKERS

 #29
20110268727
2011-11-03

ANTI-INTERFERON-ALPHA ANTIBODIES

 #30
20110206663
2011-08-25

Anti-interferon-α antibodies

 #31
20090142769
2009-06-04

Methods for determining anti-TNF therapeutic response

 #32
20080102072
2008-05-01

MONOCLONAL ANTIBODIES TO TYPE I INTERFERON RECEPTOR

 #33
20070117145
2007-05-24

Interferon-alpha induced genes

 #34
20070059309
2007-03-15

Anti-interferon-α antibodies

 #35
20070048311
2007-03-01

Anti-interferon-α antibodies

 #36
20060020118
2006-01-26

Monoclonal antibodies to type I interferon receptor

 #37
20060009482
2006-01-12

Screening method for identifying compounds that selectively induce interferon alpha

 #38
20050282179
2005-12-22

Biomarkers for interferon-alpha response in hepatitis C virus infected patients

 #39
20050202438
2005-09-15

Rational directed protein evolution using two-dimensional rational mutagenesis scanning